Podcast
Questions and Answers
Based on the World Health Organization pain ladder, the medication of choice for mild pain related to pancreatitis should be which of the following?
Based on the World Health Organization pain ladder, the medication of choice for mild pain related to pancreatitis should be which of the following?
Nonsteroidal anti-inflammatory drug and acetaminophen combination = Pain management is crucial for patients who are experiencing pancreatitis, regardless of the diagnosis being acute, chronic, or drug induced. Pain is a common symptom associated with pancreatitis, affecting as many as 90% of patients with chronic pancreatitis (CP). Pain management will be directed to the specific type of pancreatitis as well as the severity of the diagnosis. Many studies looking at pain management in patients with AP have looked at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids, such as pethidine, fentanyl, morphine, pentazocine, procaine, and many others. A systematic review of these trials found that there was no significant difference in the change of pain scores for patients when comparing the use of NSAIDs with opioids. Pain management for pancreatitis typically follows the World Health Organizations analgesic ladder. In terms of treatment options for analgesia, we begin with NSAID use and paracetamol. If this combination is ineffective, we move to drugs such as tramadol—a low-potency opioid. If a patient does require the use of opioid medications, we start with the lowest effective dose and pair it with selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, or gabapentinoids (e.g., pregabalin and gabapentin). These treatments can last days to months, depending on the patient and his or her response to CP. The patient should be aware that these treatments will not eliminate the pain but instead make the pain much more manageable. Pain management via nerve block may also be done for patients who are in considerable pain for long periods of time. Low-dose opioid = Pain management is crucial for patients who are experiencing pancreatitis, regardless of the diagnosis being acute, chronic, or drug induced. Pain is a common symptom associated with pancreatitis, affecting as many as 90% of patients with chronic pancreatitis (CP). Pain management will be directed to the specific type of pancreatitis as well as the severity of the diagnosis. Many studies looking at pain management in patients with AP have looked at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids, such as pethidine, fentanyl, morphine, pentazocine, procaine, and many others. A systematic review of these trials found that there was no significant difference in the change of pain scores for patients when comparing the use of NSAIDs with opioids. Pain management for pancreatitis typically follows the World Health Organizations analgesic ladder. In terms of treatment options for analgesia, we begin with NSAID use and paracetamol. If this combination is ineffective, we move to drugs such as tramadol—a low-potency opioid. If a patient does require the use of opioid medications, we start with the lowest effective dose and pair it with selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, or gabapentinoids (e.g., pregabalin and gabapentin). These treatments can last days to months, depending on the patient and his or her response to CP. The patient should be aware that these treatments will not eliminate the pain but instead make the pain much more manageable. Pain management via nerve block may also be done for patients who are in considerable pain for long periods of time. High-dose opioid = Pain management is crucial for patients who are experiencing pancreatitis, regardless of the diagnosis being acute, chronic, or drug induced. Pain is a common symptom associated with pancreatitis, affecting as many as 90% of patients with chronic pancreatitis (CP). Pain management will be directed to the specific type of pancreatitis as well as the severity of the diagnosis. Many studies looking at pain management in patients with AP have looked at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids, such as pethidine, fentanyl, morphine, pentazocine, procaine, and many others. A systematic review of these trials found that there was no significant difference in the change of pain scores for patients when comparing the use of NSAIDs with opioids. Pain management for pancreatitis typically follows the World Health Organizations analgesic ladder. In terms of treatment options for analgesia, we begin with NSAID use and paracetamol. If this combination is ineffective, we move to drugs such as tramadol—a low-potency opioid. If a patient does require the use of opioid medications, we start with the lowest effective dose and pair it with selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, or gabapentinoids (e.g., pregabalin and gabapentin). These treatments can last days to months, depending on the patient and his or her response to CP. The patient should be aware that these treatments will not eliminate the pain but instead make the pain much more manageable. Pain management via nerve block may also be done for patients who are in considerable pain for long periods of time. Abdominal nerve block = Pain management is crucial for patients who are experiencing pancreatitis, regardless of the diagnosis being acute, chronic, or drug induced. Pain is a common symptom associated with pancreatitis, affecting as many as 90% of patients with chronic pancreatitis (CP). Pain management will be directed to the specific type of pancreatitis as well as the severity of the diagnosis. Many studies looking at pain management in patients with AP have looked at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids, such as pethidine, fentanyl, morphine, pentazocine, procaine, and many others. A systematic review of these trials found that there was no significant difference in the change of pain scores for patients when comparing the use of NSAIDs with opioids. Pain management for pancreatitis typically follows the World Health Organizations analgesic ladder. In terms of treatment options for analgesia, we begin with NSAID use and paracetamol. If this combination is ineffective, we move to drugs such as tramadol—a low-potency opioid. If a patient does require the use of opioid medications, we start with the lowest effective dose and pair it with selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, or gabapentinoids (e.g., pregabalin and gabapentin). These treatments can last days to months, depending on the patient and his or her response to CP. The patient should be aware that these treatments will not eliminate the pain but instead make the pain much more manageable. Pain management via nerve block may also be done for patients who are in considerable pain for long periods of time.
Study Notes
Side Effects of Ranitidine
- Ranitidine, and other H2-blockers, can cause confusion, headache, erectile dysfunction, and nausea.
- Other potential side effects include dizziness, constipation, abdominal pain, diarrhea, vomiting, blurred vision, malaise, and weakness.
Short-Acting Beta Agonist and Montelukast
- A 16-year-old boy with shortness of breath, an asthma exacerbation, and daily use of albuterol was prescribed montelukast.
- Montelukast is a leukotriene antagonist.
- It blocks the action of leukotrienes on cysteinyl leukotriene receptors.
Sweat Chloride Level and Cystic Fibrosis
- A sweat chloride level above 60 mmol/L confirms cystic fibrosis.
- Dornase alfa is a mucolytic medication that depolymerizes DNA polymers, found in excess in cystic fibrosis sputum.
- This reduces sputum viscosity.
Vitamin B12 Deficiency
- A 65-year-old man with fatigue, gait imbalance, hypothyroidism, and vitiligo, and pancytopenia, likely has vitamin B12 deficiency.
- Monitoring serum potassium is important in patients with megaloblastic anemia.
Hypertriglyceridemia Treatment
- A patient with hypertriglyceridemia may be treated with niacin and a second drug specifically lowering triglycerides.
- One mechanism of action for such a drug is increasing triglyceride hydrolysis by lipoprotein lipase.
- Alternately, fibrates increase lipoprotein lipase activity, potentially reducing VLDL secretion.
Acne Keloidalis Nuchae
- Acne keloidalis nuchae (AKN) frequently is complicated by foreign body reactions and superinfection.
- Intralesional triamcinolone can reduce keloid formation and shrink AKN.
- Short haircuts, close shaving, and tight-collared shirts and headgear can help reduce the risk of infections.
Endocarditis
- A 45-year-old man who recently underwent wisdom tooth extraction developed endocarditis; symptoms included fever,erythematous, papular lesions, white-centered retinal hemorrhages, red urine, and edema.
- Amoxicillin is the preferred prophylactic antibiotic for patients with valve damage undergoing dental procedures.
Diarrhea
- Diarrhea is a common side effect of amoxicillin.
- Other common side effects of treatment of amoxicillin are not listed.
Infectious Mononucleosis
- Infectious mononucleosis is characterized by lymphocytosis, or increased numbers of circulating activated T lymphocytes.
- Downey cells are enlarged lymphocytes that are a characteristic finding of infectious mononucleosis.
Clotrimazole
- Clotrimazole inhibits the fungal cytochrome P450 enzyme.
- Ergosterol is the main fungal cell membrane sterol.
- Clotrimazole inhibits ergosterol formation, impairing cell membrane function.
Testicular Carcinoma
- A 28-year-old man experiencing pain and heaviness in his right testicle required an orchidectomy.
- Cisplatin is a chemotherapeutic agent, and may cause nephrotoxicity.
PPARY Receptors
- PPARY receptors are activated by thiazolidinediones to increase tissue sensitivity to insulin.
- PPARY activation leads intracellular cAMP increase and GLUT2 inactivation.
Androgen Therapy Side Effects
- A teenage boy undergoing androgen therapy for hypogonadism may experience gynecomastia, prolonged erections, a change in voice pitch, urinary frequency, and visual disturbances.
- Priapism, and other issues with sperm count, are also potential outcomes.
Leuprolide and Ganirelix
- Leuproline is a GnRH agonist and ganirelix is an antagonist.
- Ganirelix immediately stops gonadotropin secretion.
- Leuprolide takes a week to stop gonadotropin secretion
Pancreatitis Pain Management
- Pain management is important for patients with pancreatitis.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen can be used.
- Low-dose opioids or other low-potency opioids like tramadol may also be used.
Matrix Metalloproteinases (MMPs)
- Matrix metalloproteinases (MMPs), MMP-1, MMP-9, and MMP-12, are involved in emphysema development.
- MMPs are extracellular matrix-degrading enzymes which may have a role in tissue destruction and inflammation.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz explores the side effects of ranitidine, the use of montelukast for asthma management, diagnostic criteria for cystic fibrosis through sweat chloride levels, and the implications of vitamin B12 deficiency. Each topic underscores the importance of understanding medication effects and disease management strategies.